Follow
Teemu Tolonen
Teemu Tolonen
patologi
Verified email at fimlab.fi
Title
Cited by
Cited by
Year
Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer
KA Leinonen, OR Saramäki, B Furusato, T Kimura, H Takahashi, S Egawa, ...
Cancer epidemiology, biomarkers & prevention 22 (12), 2333-2344, 2013
1552013
Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer
KA Leinonen, TT Tolonen, H Bracken, UH Stenman, TLJ Tammela, ...
Clinical Cancer Research 16 (10), 2845-2851, 2010
1342010
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen, IM Coleman, D Vodák, ...
Cell reports 19 (10), 2045-2059, 2017
1232017
EZH2, Ki‐67 and MCM7 are prognostic markers in prostatectomy treated patients
S Laitinen, PM Martikainen, T Tolonen, J Isola, TLJ Tammela, T Visakorpi
International journal of cancer 122 (3), 595-602, 2008
1182008
ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry
VJ Tuominen, TT Tolonen, J Isola
Histopathology 60 (5), 758-767, 2012
952012
Dual‐specificity phosphatase 1 and serum/glucocorticoid‐regulated kinase are downregulated in prostate cancer
HE Rauhala, KP Porkka, TT Tolonen, PM Martikainen, TLJ Tammela, ...
International journal of cancer 117 (5), 738-745, 2005
952005
Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections–a randomized controlled trial
KE Hietanen, TA Järvinen, H Huhtala, TT Tolonen, HO Kuokkanen, ...
Journal of Plastic, Reconstructive & Aesthetic Surgery 72 (1), 4-11, 2019
912019
Atorvastatin versus placebo for prostate cancer before radical prostatectomy—a randomized, double-blind, placebo-controlled clinical trial
TJ Murtola, H Syvälä, T Tolonen, M Helminen, J Riikonen, J Koskimäki, ...
European urology 74 (6), 697-701, 2018
652018
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ...
Nature communications 12 (1), 5307, 2021
622021
Overall and worst Gleason scores are equally good predictors of prostate cancer progression
TT Tolonen, PM Kujala, TLJ Tammela, VJ Tuominen, JJ Isola, T Visakorpi
BMC urology 11, 1-6, 2011
542011
Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy
DJ Woodcock, E Riabchenko, S Taavitsainen, M Kankainen, G Gundem, ...
Nature communications 11 (1), 5070, 2020
512020
Cytokeratin-supervised deep learning for automatic recognition of epithelial cells in breast cancers stained for ER, PR, and Ki-67
M Valkonen, J Isola, O Ylinen, V Muhonen, A Saxlin, T Tolonen, M Nykter, ...
IEEE transactions on medical imaging 39 (2), 534-542, 2019
502019
Microseminoprotein-beta expression in different stages of prostate cancer
L Sjöblom, O Saramäki, M Annala, K Leinonen, J Nättinen, T Tolonen, ...
PloS one 11 (3), e0150241, 2016
402016
Optimized JPEG 2000 compression for efficient storage of histopathological whole-slide images
H Helin, T Tolonen, O Ylinen, P Tolonen, J Napankangas, J Isola
Journal of pathology informatics 9 (1), 20, 2018
392018
Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
GS Bova, HML Kallio, M Annala, K Kivinummi, G Högnäs, S Häyrynen, ...
Molecular Case Studies 2 (3), a000752, 2016
332016
CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations
A Khanna, JK Rane, KK Kivinummi, A Urbanucci, MA Helenius, ...
Oncotarget 6 (23), 19661, 2015
322015
Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki‐67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine‐treated …
TT Tolonen, TLJ Tammela, PM Kujala, VJ Tuominen, JJ Isola, T Visakorpi
BJU international 108 (9), 1430-1438, 2011
292011
Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts
K Savolainen, M Scaravilli, A Ilvesmäki, S Staff, T Tolonen, JU Mäenpää, ...
BMC research notes 13, 1-7, 2020
272020
Computer-aided breast cancer histopathological diagnosis: Comparative analysis of three DTOCS-based features: SW-DTOCS, SW-WDTOCS and SW-3-4-DTOCS
I Pöllänen, B Braithwaite, T Ikonen, H Niska, K Haataja, P Toivanen, ...
2014 4th International Conference on Image Processing Theory, Tools and …, 2014
252014
Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer
M Sainio, T Visakorpi, T Tolonen, J Ilvesaro, GS Bova
Pathology-Research and Practice 214 (6), 848-856, 2018
242018
The system can't perform the operation now. Try again later.
Articles 1–20